Stocktoria

Check-Cap Ltd MBAI

Nasdaq · stock · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · website · IPO 2015-02-19 · LEI

Check-Cap Ltd (MBAI) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend.

Chart by TradingView
22/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 2 3 1 3 3 2 2 1 2 2016201720182019202020212022202320242025
Altman Z″
0.81 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$1.27 as of 2026-08-01 · -75.3% 1y
$1.27$14.8452-wk
Market cap USD$8M
P / E1.8×
Return on equity 5y avg-8.5%
Beta0.76

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 12%
Return on equitystronger than 99%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MBAICheck-Cap Ltd2/91.8
GEHCGE HealthCare Technologies Inc.4/91.9914.4+4.8%
BFLYButterfly Network, Inc.3/9-5.51+19%
NNOXNano-X Imaging Ltd.2/9-3.7+15.4%
VFSVinFast Auto Ltd.4/9-13.01+57.9%
TMTOYOTA MOTOR CORP/7/92.55-1%
HMCHONDA MOTOR CO LTD6/92.79+19.9%

All Manufacturing companies →

About Check-Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

FAQ

Is MBAI financially healthy?

Check-Cap Ltd's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does MBAI pay a dividend?

No, Check-Cap Ltd does not currently pay a dividend.

How profitable is MBAI?

In FY2025, Check-Cap Ltd had a return on equity of 120.5%.

Is MBAI overvalued or undervalued?

Check-Cap Ltd trades at about 1.9× trailing earnings — below its 10-year norm (10-year range 6.3×–23.8×, median 19.3×). Stocktoria reports the data, not buy/sell advice.

Is MBAI a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Check-Cap Ltd: a Piotroski F-score of 2/9, a P/E of about 1.8×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.